The rate of BCR-ABL1 decline after TKI commencement is a strong predictor of sustained treatment free remission. Shanmuganathan N, Branford S, Pagani IS, Ross, DM, Park S, Yong ASM, Braley J, Altamura H, Hiwase DK, Yeung DT, Kim D-W and Hughes TP.
- Pagani, I. (Speaker)
Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks